â– LECTURE OVERVIEW: Preventative medicine divides interventions into four distinct levels, organized chronologically by their relationship to the pathological cascade.
â– INTERVENTION TIERS:
1. Primordial Prevention: Prevents the development and establishment of systemic risk factors. Focuses on social and environmental policies (e.g., child sports funding).
2. Primary Prevention: Controls risk factors prior to disease onset. Focuses on health promotion and specific protection to prevent pathological damage (e.g., smoking cessation, vaccinations, seat belts).
3. Secondary Prevention: Focuses on early diagnosis and prompt treatment. Aims to arrest pathological progression before permanent damage occurs (e.g., screening mammography, Pap smears, routine BP checks).
4. Tertiary Prevention: Restricts disability and assists rehabilitation. Implemented post-damage to restore optimal function (e.g., physiotherapy after stroke, beta-blocker therapy after myocardial infarction).
â– BIOCHEMICAL MECHANISMS:
At the molecular level, enzyme kinetics govern reaction rates. Competitive inhibitors raise apparent Michaelis constants without changing maximum speed, whereas noncompetitive inhibitors decrease maximum speed directly.
â– PHARMACODYNAMIC TARGET ENGAGEMENT:
Receptor binding dynamics dictate the overall speed, duration, and magnitude of physiological responses to therapeutic agents.
[HY-BOARD-1370]
🌟 Dynamic Clinical Key:
Distinguishing primary from secondary prevention: Administering folic acid to pregnant women to prevent neural tube defects is Primary prevention. Performing an ultrasound at 18 weeks to screen for neural tube anomalies is Secondary prevention. Focus on rate-limiting regulatory steps for pharmacological design. Watch closely for ligand-receptor saturation effects and subsequent tolerance or resistance.